1. Home
  2. IOVA vs QNST Comparison

IOVA vs QNST Comparison

Compare IOVA & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.97

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo QuinStreet Inc.

QNST

QuinStreet Inc.

HOLD

Current Price

$12.44

Market Cap

870.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
QNST
Founded
2007
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
870.0M
IPO Year
2008
2009

Fundamental Metrics

Financial Performance
Metric
IOVA
QNST
Price
$3.97
$12.44
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
$9.11
$24.75
AVG Volume (30 Days)
16.9M
816.7K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.84
N/A
EPS
N/A
0.94
Revenue
N/A
$282,140,000.00
Revenue This Year
$49.14
$18.59
Revenue Next Year
$51.69
$14.96
P/E Ratio
N/A
$12.96
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$10.29
52 Week High
$5.63
$19.53

Technical Indicators

Market Signals
Indicator
IOVA
QNST
Relative Strength Index (RSI) 52.57 54.22
Support Level $1.99 $10.79
Resistance Level $4.34 $12.62
Average True Range (ATR) 0.50 0.46
MACD -0.00 0.17
Stochastic Oscillator 28.72 87.98

Price Performance

Historical Comparison
IOVA
QNST

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.

Share on Social Networks: